Paper

Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trial

Nature Medicine · 2026 · Priscilla Merriam, James J Morrow, Emanuele Mazzola et al.